We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-6.88%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.39B
AUM Growth
-$1.88B
Cap. Flow
-$1.67B
Cap. Flow %
-49.21%
Top 10 Hldgs %
42.09%
Holding
110
New
24
Increased
17
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$163M
2
NXPI icon
NXP Semiconductors
NXPI
+$72.5M
3
PTCT icon
PTC Therapeutics
PTCT
+$72M
4
CI icon
Cigna
CI
+$64.7M
5
SAGE
Sage Therapeutics
SAGE
+$62.5M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$217M
2
HUM icon
Humana
HUM
+$149M
3
ICUI icon
ICU Medical
ICUI
+$97.4M
4
BABA icon
Alibaba
BABA
+$84.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$83.1M

Sector Composition

Rank Sector Weight
1 Healthcare 59.59%
2 Technology 15.32%
3 Financials 1.11%
4 Communication Services 1.02%
5 Consumer Discretionary 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
51
Fate Therapeutics
FATE
$286M
$13.7M 0.4%
881,002
-666,728
-43% -$12.8M
BABA icon
52
Alibaba
BABA
$293B
$13.6M 0.4%
81,204
-490,172
-86% -$84.2M
LYV icon
53
Live Nation Entertainment
LYV
$40.5B
$13.1M 0.39%
+197,341
New +$13.8M
VC icon
54
Visteon
VC
$2.79B
$12.3M 0.36%
+149,584
New +$9.98M
TECX
55
Tectonic Therapeutic
TECX
$529M
$11.1M 0.33%
65,331
+44,545
+214% +$10.1M
GS icon
56
Goldman Sachs
GS
$300B
$9.81M 0.29%
+47,320
New +$9.9M
AXNX
57
DELISTED
Axonics, Inc. Common Stock
AXNX
$6.77M 0.2%
251,461
+145,133
+136% +$5.06M
KRTX
58
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.7M 0.2%
410,643
-362,388
-47% -$7.04M
ACOR
59
DELISTED
Acorda Therapeutics
ACOR
$6.28M 0.19%
+18,219
New +$9.9M
DLPH
60
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$5.75M 0.17%
+429,452
New +$6.81M
EIDX
61
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$4.54M 0.13%
+126,181
New +$4.93M
EQ icon
62
Equillium
EQ
$139M
$4.05M 0.12%
1,064,979
-345,853
-25% -$1.49M
TW icon
63
Tradeweb Markets
TW
$21.4B
$2.48M 0.07%
67,157
– –
ALNA
64
DELISTED
Allena Pharmaceuticals
ALNA
$1.92M 0.06%
486,978
-301,980
-38% -$1.3M
LVGO
65
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$1.85M 0.05%
+106,380
New +$3.22M
PYPL icon
66
PayPal
PYPL
$48.9B
$1.58M 0.05%
15,236
-507,210
-97% -$55.9M
ELGX
67
DELISTED
Endologix Inc
ELGX
$1.01M 0.03%
+253,890
New +$1.48M
AMK
68
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$762K 0.02%
+29,259
New +$785K
ALGN icon
69
Align Technology
ALGN
$12.1B
– –
-155,459
Closed -$42.5M
AMGN icon
70
CALL
Amgen
AMGN
$208B
– –
-176,600
Closed -$32.5M
AMGN icon
71
PUT
Amgen
AMGN
$208B
– –
-831,900
Closed -$153M
AVTR icon
72
Avantor
AVTR
$9.32B
– –
-999,873
Closed -$19.1M
CRWD icon
73
CrowdStrike
CRWD
$194B
– –
-233,536
Closed -$3.99M
DBX icon
74
Dropbox
DBX
$7.6B
– –
-608,087
Closed -$15.2M
DIS icon
75
Walt Disney
DIS
$167B
– –
-398,702
Closed -$55.7M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2019 Portfolio in Review

As of Q3 2019, PFM Health Sciences held 110 positions worth $3.39B, down 36% from $5.26B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

PFM Health Sciences withdrew a net $1.67B in Q3 2019, closing 38 positions and reducing 27 holdings. Its most notable exit was Humana, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Alexion Pharmaceuticals worth $142M.

  • PFM Health Sciences's largest Q3 2019 buy was Alexion Pharmaceuticals: 1,446,612 shares worth $142M.
  • PFM Health Sciences added most to uniQure in Q3 2019, an estimated $56.8M increase.
  • PFM Health Sciences's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $217M.
  • PFM Health Sciences fully exited Humana in Q3 2019, selling an estimated $149M.
  • PFM Health Sciences's ten largest holdings make up 42% of its $3.39B portfolio in Q3 2019.
  • PFM Health Sciences opened 24 new positions and closed 38 in Q3 2019.
  • PFM Health Sciences's portfolio value fell 36% quarter-over-quarter to $3.39B.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.